Eagle Pharmaceuticals releases unaudited Q1 2025 financial statements for the three months ending March 31, 2025. OTMKTS: EGRX.

Unusual Whales
2025.10.06 23:31
Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) based in Woodcliff Lake, New Jersey, released unaudited financial statements for the quarter ending March 31, 2025. The announcement was made on October 6, 2025. The financial information can be accessed on the company's website at the following link: https://investor.eagleus.com/events-presentations.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer